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An epidemic of tuberculosis occurred in a community of Aboriginal Canadians during the period 1987–89. Genetic
and epidemiologic data were collected on an extended family from this community, and the evidence for linkage
to NRAMP1, a candidate gene for susceptibility to mycobacterial diseases, was assessed. Individuals were grouped
into risk (liability) classes based on vaccination, age, previous disease, and tuberculin skin-test results. Under the
assumption of a dominant mode of inheritance and a relative risk of 10, which is associated with the high-risk
genotypes, a maximum LOD score of 3.81 was observed for linkage between a tuberculosis-susceptibility locus
and D2S424, which is located just distal to NRAMP1, in chromosome region 2q35. Significant linkage was also
observed between a tuberculosis-susceptibility locus and a haplotype of 10NRAMP1 intragenic variants. No linkage
to the major histocompatibility-complex region on chromosome 6p was observed, despite distortion of transmission
from one member of the oldest couple to their affected offspring. The ability to assign individuals to risk classes
was crucial to the success of this study.
Introduction
Tuberculosis caused by the human pathogenic bacterium
Mycobacterium tuberculosis is a major global public-
health problem. In 1997, it was estimated that world-
wide there were 7.96 million new cases of tuberculosis
(136/100,000 persons), in addition to 8.22 million ex-
isting cases, and that 1.87 million people died of tuber-
culosis (Dye et al. 1999). In Canada, the incidence of
tuberculosis is low and was estimated at 7/100,000 (see
Appendix 3 in Dye et al. 1999). However, this low rate
is not evenly distributed among the Canadian popula-
tion. Approximately 60% of all cases of tuberculosis
occur in immigrants from countries where tuberculosis
is endemic, and 15% of the cases occur in the Aboriginal
Canadian population, where the annual rate is ∼70/
100,000 (Fanning 1999).
It has been argued that people of European origin
have a high level of resistance to infection by M. tu-
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berculosis, because of selection for host resistance over
300 years, whereas Aboriginal American populations
may be more susceptible, since exposure to M. tuber-
culosis was rare prior to 1880 (reviewed in Stead 1997).
Twin studies (Kallmann and Reisner 1943) and a seg-
regation analysis (Shaw et al. 1997) support a role for
a genetic basis of susceptibility. Although there have
been many studies examining the relationship between
known genes involved in human immune function and
tuberculosis, results have not been consistent. A com-
prehensive summary by Meyer et al. (1998) showed that
there is evidence to support a role for the major his-
tocompatibility complex (MHC) region in disease pro-
gression but that the role of MHC in resistance to in-
fection is still controversial.
In laboratory strains of inbred mice, it was shown
that resistance/susceptibility to the early growth of M.
bovis (BCG [Bacille Calmette-Gue´rin]) is controlled by
a locus named “Bcg” and that resistance is inherited as
a dominant trait (Gros et al. 1981). Subsequently, on
mouse chromosome 1, a gene called “Nramp1” (natural
resistance–associated macrophage protein 1) was iden-
tified that controls resistance to M. bovis (BCG) and
other unrelated intracellular parasites (Vidal et al. 1993,
1995; reviewed in Skamene et al. 1998). The same locus
was shown to control early growth of mycobacteria in
mice infected with M. lepraemurium, M. intracellulare,
M. smegmatis, M. avium, and a group of atypical my-
cobacteria (reviewed in Schurr and Skamene 1995). The
human orthologue, NRAMP1, was cloned and mapped
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to chromosome region 2q35 (Cellier et al. 1994), and
variants within the gene were characterized (Liu et al.
1995a). Associations between four polymorphisms in
NRAMP1 and susceptibility to tuberculosis were shown
in patients from western Africa; susceptibility appeared
to act in a dominant manner, in contrast to the mouse
model, where susceptibility is recessive (Bellamy et al.
1998). Susceptibility to leprosy has been linked to
NRAMP1 in a sample of 20 nuclear families from Vi-
etnam (Abel et al. 1998). Searle and Blackwell (1999)
presented evidence that a polymorphic dinucleotide re-
peat in the NRAMP1 promoter region influenced gene
expression in a luciferase assay. They suggested that an
allele that drives low reporter-gene expression contrib-
utes to infectious-disease susceptibility, whereas an al-
lele that drives high expression contributes to autoim-
mune-disease susceptibility. Previously, Blackwell et al.
(1997) had reported an association between this pro-
moter-region polymorphism and susceptibility to tu-
berculosis in 72 age- and sex-matched Brazilian cases
and controls. In 37 multicase Brazilian families, Shaw
et al. (1997) found weak evidence for linkage between
tuberculosis and a highly polymorphic marker adjacent
to NRAMP1; however, they found no evidence for link-
age to NRAMP1. Hence, the potential role ofNRAMP1
in the modulation of tuberculosis susceptibility remains
controversial.
An extended Aboriginal Canadian family was ex-
posed to M. tuberculosis and experienced an epidemic
of tuberculosis (Mah and Fanning 1991). Given the
proved role of Nramp1 in mycobacterial susceptibility
in the mouse, human NRAMP1 was chosen as a can-
didate gene for tuberculosis susceptibility, and linkage
analysis was undertaken in this family, primarily to as-
sess the role of NRAMP1.
Subjects and Methods
Family Enrollment and Diagnosis
All subjects enrolled in the present study were mem-
bers of an extended Aboriginal Canadian family that
experienced an outbreak of tuberculosis during 1987–89
(Mah and Fanning 1991). The study was approved by
the Research Ethics Board of the University of Alberta.
All family members were seen, during the outbreak, by
the same physician, and standard forms used by the Al-
berta Health Tuberculosis Services were completed. Case
records and diagnostic criteria were reviewed after the
outbreak, and each individual was classified as having
a particular disease phenotype (Miller 1991); a synopsis
follows. Respiratory-tract specimens (obtained by na-
sopharyngeal suction or gastric lavage in children) were
sent to the Alberta Public Health Laboratory, for my-
cobacterial culture. A positive culture had either evi-
dence of visible growth on solid media or a growth index
199 in the radiometric system. The species of mycobac-
teria were identified by conventional methods. In ad-
dition, microscopic screening for acid-fast bacilli was
done by the auramine-O fluorescent method followed
by Kinyoun staining. The disease phenotypes were de-
fined as follows: “culture-positive case”—presence of
one or more symptoms or signs associated with tuber-
culosis (i.e., fever, cough, weight loss, pulmonary infil-
trate not responsive to conventional antibiotics, and
night sweats) during the period of the epidemic and iso-
lation of M. tuberculosis from respiratory secretions;
“culture-negative case”—presence of one or more symp-
toms or signs associated with tuberculosis, clinical re-
sponse to antituberculous drugs including chest radio-
logical clearing, and a mycobacteria-negative culture of
respiratory secretions; “old case”—tuberculosis disease
diagnosed, treated, and presumed to have been cured
prior to the epidemic; and “no disease”—absence of dis-
ease as defined above. There were no cases of miliary
or other forms of extrapulmonary tuberculosis. The cul-
ture-negative cases also were negative for acid-fast–
bacilli staining; these individuals tended to be young.
Chest radiography was done on all subjects. Radiolog-
ical abnormalities considered to be consistent with active
tuberculosis included noncalcified hilar or paratracheal
adenopathy and/or parenchymal infiltration. In statis-
tical analyses, we considered culture-positive and cul-
ture-negative cases as affected and considered no-disease
and old-case individuals as unaffected.
Among previously uninfected individuals who had
never been vaccinated with BCG, a new infection with
M. tuberculosis was diagnosed by a skin reaction with
110 mm induration, in response to intradermal injection
of 5 tuberculin units of purified protein derivative (PPD)
(Mah and Fanning 1991). Individuals were assumed to
have been previously uninfected if they either (i) had had
a prior negative PPD test (14 individuals tested negative
during 1968–81, and 15 individuals tested negative early
during the epidemic) or (ii) were not known to have had
any prior contact with tuberculosis and had had no prior
PPD test (24 individuals). A partial pedigree that has
been altered for publication is shown in figure 1.
Genetic Epidemiology
The risk of developing tuberculosis was assumed to
vary among individuals, on the basis of available phe-
notypic, clinical, and historical information. In order to
model gene-environment interaction in a parametric
LOD-score linkage model, four risk (liability) classes
were created that depended on age, BCG-vaccination
status, tuberculin skin-test results, and previous infection
and disease. Each individual was assigned to one liability
class. The penetrances in each class were estimated on
the basis of published studies and reviews of tubercu-
losis, as well as on the basis of observations of this ex-
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Table 1
Penetrance Values and Prevalences for Linkage Analysis, for the
Phenotype of Tuberculosis Disease
LIABILITY
CLASSa
PENETRANCE OFb
ESTIMATED
DISEASE
PREVALENCEc
NO. OF
INDIVIDUALS
Low-Risk
Genotype
High-Risk
Genotype Total Affected
1 .085 .85 .16 42 19
2 .037 .37 .07 11 0
3 .010 .10 .02 7 0
4 .425 .85 .47 7 5
Unknownd 14 …
a 1 = Previously unexposed; 2 = previously exposed, vaccinated, or
previously treated for disease; 3 = PPD negative during epidemic; 4 =
very young or elderly.
b Penetrance of the heterozygote was assumed to be equal to that
of either the low-risk or the high-risk homozygote, depending on
whether a recessive or a dominant mode of inheritance, respectively,
was assumed.
c Based on an assumed disease-allele frequency of .05, a dominant
mode of inheritance, and the penetrances shown.
d Ancestors not exposed during the epidemic.
Figure 1 Partial pedigree of the extended kindred. The five culture-negative cases (individuals 10, 13, 15, 21, and 22) had radiological
abnormalities consistent with active tuberculosis; individuals 10 and 15 also had symptoms associated with tuberculosis. Not included in the
pedigree are nine individuals from whom DNA was not available and among whom there were two infants classified as culture-negative cases
(both had radiological abnormalities), three children classified as not having disease (all PPD negative; two were culture negative, and no culture
was taken from the third), and four people with unknown disease phenotype. The order of the information below each circle is as follows:
mycobacterial test result (c = M. tuberculosis culture positive; c = M. tuberculosis culture negative; nd = no data), liability class, NRAMP1
haplotype, D2S424 alleles, and TNF haplotype. D2S424 alleles 1, 2, and 3 are 185, 181, and 157 bp, respectively. BCG indicates that the
individual was vaccinated. For classification of disease phenotype and definition of liability classes, see the Subjects and Methods section; for
NRAMP1 andTNF haplotypes, see tables 2 and 3, respectively.
tended family and the surrounding community (Booth-
royd 1994); table 1 gives the assumed penetrances for
the four liability classes. Liability class 1 consisted of
individuals who, as the result of exposure to tuberculosis
during the epidemic, converted from PPD negative (i.e.,
either known to be negative or, in the absence of test
results, assumed to be negative) to PPD positive. The
penetrance of the high-risk genotype was assumed to be
.85. Approximately 15% of the family members tested
PPD negative during the epidemic, and therefore this
number was used as an index of insufficient exposure.
Liability class 2 included individuals who either (a) pre-
viously had been vaccinated with BCG, (b) were PPD
positive prior to the epidemic but were not known to
have had the disease, or (c) previously had been affected
with tuberculosis and had been successfully treated.
These individuals were assumed to have a lower risk of
disease at subsequent exposure (Ferguson 1955). The
penetrance of the high-risk genotype (i.e., .37) was based
on a case-control study of vaccine efficacy in Aboriginal
Canadians that showed a 57% reduction in risk (Hous-
ton et al. 1990). Liability class 3 included individuals
who were PPD negative for tests at two different times
and who therefore may have been unexposed or not
intensively exposed to M. tuberculosis. Their high-risk
genotype penetrance of .10 was adapted from an esti-
mate of the false-negative rate in PPD tests (Holden et
al. 1971; Boothroyd 1994). Finally, liability class 4 in-
cluded individuals who were 2 or 65 years of age
and, because of an immature or a compromised immune
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Figure 2 YAC contig of the NRAMP1-gene region. The names of loci and chromosome 2–specific IRS probes are indicated at the top
of the figure. YAC clones are represented as bars; the YAC address is given to the left of the bar. The blackened area of each bar indicates that
the YAC was unambiguously identified by the probe listed directly above the YAC; the unblackened area of each bar indicates that the probe
did not hybridize with the YAC; and the gray-shaded area of each bar indicates that the YAC was not tested for the presence of the probe.
D2S1471 was not included in STS contig mapping; the order NRAMP1–VIL–D2S1471 was established by physical mapping in a PAC contig
(Abel et al. 1998).
system, were considered to be at high risk of disease.
Their high-risk penetrance was assumed to be .85, as in
liability class 1. The genotype relative risk, or the ratio
of the penetrance of the high-risk genotype to the low-
risk genotype, was assumed to be 10 in liability classes
1–3, but in liability class 4, even in individuals who did
not carry any susceptibility alleles, the risk of disease
was assumed to be much higher, such that a relative risk
of 2 was assumed for this group. The frequency of the
high-risk allele was assumed to be .20 for a recessive
model and .05 for a dominant model; a fairly high allele
frequency is plausible, given the history of the com-
munity. Estimated disease prevalences were based on the
dominant-model parameters (table 1). The resulting es-
timated prevalences are high (e.g., 16% in liability class
1) when compared with published tuberculosis incidence
rates, but there is evidence to support a very high sus-
ceptibility among Aboriginal Canadian peoples (Fergu-
son 1955).
Twenty-nine markers on chromosome 2q, spanning
∼71 cM, were typed, including 10 variants in either
NRAMP1 or the immediate flanking regions of the gene
(fig. 2). NRAMP1 haplotypes were deduced from the
genotypes by inspection of their segregation in the ped-
igree; table 2 shows the haplotype codes. Only one poly-
morphism in this study corresponds to a missense variant
(D543N), and analysis of this diallelic polymorphism
was undertaken separately. A separate analysis was also
undertaken for the flanking region 5′ (GT)n dinucleotide
repeat (Liu et al. 1995a); allele 286 corresponds to allele
3 in the study by Searle and Blackwell (1999), which
was shown by these investigators to drive high gene ex-
pression in vitro. In addition, on chromosome 6, two
single-nucleotide polymorphisms (SNPs) in the promoter
region of the tumor necrosis–factor gene (TNF) and six
nearby markers were genotyped, and segregating hap-
lotypes were inferred (table 3).
Genotyping
DNA samples were genotyped for microsatellite mark-
ers (see table 4) that flank NRAMP1 in chromosome
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Table 2
NRAMP1 Haplotypes
MARKER
LOCATION IN
NRAMP1
HAPLOTYPE
1 2 3 4 5
(GT)n
a,b,c 5′ Promoter region 286 286 288 288 286
77385C/Td 5′ Promoter region C T C C C
274C/Ta Codon 66, exon 3 C C T C C
46914G/Ca,c Intron 4 G G C G G
57718G/Aa Intron 5 G G G G G
823C/Ta Codon 249, exon 8 C C C T T
A318Va Codon 318, exon 9 Ala Ala Ala Ala Ala
146585G/Aa Intron 13 G G A A A
D543Na,c Codon 543, exon 15 Asp Asn Asp Asn Asn
(CAAA)n
e 3′ UTR 2 3 3 3 3
a Name of variant as defined by Liu et al. (1995a); the nucleotides
and codons were numbered according to the sequence of GenBank
accession number L32185.
b Microsatellite alleles are designated by size (in bp), SNPs by nu-
cleotides, coding variants by amino acids, and the insertion/deletion
polymorphism by number of repeat units.
c Marker used in the case-control study of western Africans, by
Bellamy et al. (1998).
d SNP (Lewis et al. 1996) nucleotide 129 (see GenBank accession
number U57604) or nucleotide 3247 (see GenBank accession number
D63507), which is 385 bp preceding the A (nucleotide 77; see GenBank
accession number L32185) in the initiation codon.
e Insertion/deletion–polymorphism (Buu et al. 1995) nucleotides
1993–2000 (see GenBank accession number L32185) and nucleotides
269–280 (see GenBank accession number U26447).
region 2q35, by standard radioactive protocols (Hudson
et al. 1997) with minor modifications. The conditions
for genotyping 8 of the 10 intragenic NRAMP1 markers
have been described elsewhere (Liu et al. 1995a). The
insertion/deletion polymorphism (CAAA)n was ampli-
fied by the forward primer reported by Buu et al. (1995)
and by the reverse primer 5′-TCAAGCTCCAGTTTG-
GAGCCT-3′ and, by electrophoresis on 10% polyac-
rylamide gels stained with ethidium bromide, was ge-
notyped as a length variant. The SNP, 77385C/T,
identified by Lewis et al. (1996) was genotyped by prim-
ers 5′-GGGTGTGGTCATGGGGTATTGA-3′ and 5′-CA
AAGGCAGAAGTGGCCAG-3′, in a similar manner to
that used for other NRAMP1 SNPs (Liu et al. 1995a).
The allele with nucleotide T creates an Msl I restriction
site. Digestion of the 202-bp PCR fragment by Msl I
results in 175-bp and 27-bp fragments for allele T and
in the 202- bp fragment for allele A. In the MHC region
on chromosome 6, we genotyped five microsatellite
markers (TNFa, TNFb, TNFc, TNFd, and TNFe) as de-
scribed by Udalova et al. 1993, and three SNPs referred
to here as “TNFn” (Udalova et al. 1993), “TNFa-308”
(Wilson et al. 1992), and “TNFA-238” (D’Alfonso and
Richiardi 1994). SNPs were genotyped by assays based
on naturally occurring or amplification-created restric-
tion sites. With minor modifications, TNFn was geno-
typed as described by Roth et al. (1994), TNFa-308 was
genotyped as described by Wilson et al. (1992), and
TNFA-238 was genotyped by Ava II digestion of frag-
ments amplified by primer 5′-CAAACACAGGCCTCA-
GGACTC-3′ (McGuire et al. 1994) and a primer—5′-
TCACACTCCCCATCCTCCCTGGTC-3′—modified to
create an Ava II site with one of the alleles.
Physical Mapping
To establish the order of microsatellites in the im-
mediate vicinity of NRAMP1, we established a YAC
contig spanning an estimated bp of geno-62.5# 10
mic DNA in the NRAMP1 region. The YAC libraries
screened consisted of the Centre d’E´tude du Polymor-
phisme Humain (CEPH) Mark I YAC library plates
numbered 1–552, plus 24 plates of the original Wash-
ington University YAC library. This setup of library
plates has been described elsewhere (Liu et al. 1995b).
In addition, the CEPH Mega YAC library plates 1–860
and 869–972 were used. From all YAC clones, inter-
spersed repetitive sequences (IRS)–PCR products were
prepared and spotted on nylon membranes, as described
elsewhere (Liu et al. 1995b). The filters were screened
by chromosome 2–specific IRS probes, and extended
chromosome 2 YAC contigs were obtained (Liu 1996).
Microsatellites (D2S301, D2S1371, D2S295, D2S434,
D2S173, D2S104, D2S433, D2S424, D2S120, and
D2S163) were selected from published genetic maps and
were placed on the YAC contig map overlapping the
NRAMP1 region. In addition, we selected primer pairs
for five known genes (IL8RB, NRAMP1, VIL, DES, and
INHA) and one sequence-tagged site (STS) (WI14333).
The source, sequence, and conditions for amplification,
except for WI14333, have been described elsewhere (Liu
et al. 1995b). The sequence and conditions for ampli-
fication of WI14333 were taken from the Whitehead
Institute for Biomedical Research/MIT Center for Ge-
nome Research Web site. All contigs were subjected to
STS contig mapping, and several contigs in chromosome
region 2q35, which contain NRAMP1, were identified.
These contigs were integrated with the Whitehead In-
stitute for Biomedical Research/MIT Center for Genome
Research YAC map, and the remaining contig gaps in
the NRAMP1 region were closed by chromosome walk-
ing in YAC libraries (Liu et al. 1995b; Liu 1996). The
relative position of microsatellite marker D2S1471 was
determined by physical mapping in a plasmid artificial
chromosome (PAC) contig, as described elsewhere (Abel
et al. 1998).
Statistical Methods
Two-point LOD scores for the four liability-class gene-
environment–interaction model (described above) were
calculated by FASTLINK version (4.1P) (Cottingham et
al.1993; Scha¨ffer et al. 1994) of the LINKAGE programs
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Table 3
Haplotypes in the TNF Region
MARKERa TYPE LOCATION b
HAPLOTYPE
1 2 3 4 5 6 7 8 9 10
TNFb (GA)n 5,119 bp 5
′ to initiation codon of LTA 131 130 131 131 129 130 127 131 131 131
TNFa (GT)n 5,066 bp 5
′ to initiation codon of LTA 97 109 109 107 99 115 99 107 103 103
TNFn SNP Intron 1 of LTA T T C C C T T C C T
TNFc (GA)n Intron 1 of LTA 161 159 159 159 159 159 161 159 159 161
TNFa-308 SNP Promoter region of TNF C C C C T C C C T C
TNFA-238 SNP Promoter region of TNF T C C C C C C C C C
TNFe (TC)n Intron 4 of LST1 104 104 104 104 104 104 100 104 104 104
TNFd (TC)n Intron 4 of LST1 130 130 130 134 126 130 132 130 130 134
a Names of markers are according to Wilson et al. (1992), Udalova et al. (1993), D’Alfonso and Richiardi (1994), and Roth et al.
(1994). Microsatellite alleles are designated in terms of size (in bp) and SNPs are designated in terms of nucleotides.
b Order and location of genes are as follows: telomere–LTA–TNF–LST1–centromere. Intermarker distances, according to GenBank
accession number Y14768, are as follows: TNFb—(21 bp)— TNFa—(4,858 bp)—TNFn—(168 bp)—TNFc—(2,531 bp)—TNFa-
308—(69 bp)—TNFA-238—(12,900 bp)—TNFe—(132 bp)—TNFd.
(Lathrop and Lalouel 1984; Lathrop et al. 1984, 1986).
The pedigree contained four loops. Marker-allele fre-
quencies in the founders of the pedigree were estimated
by the ILINK program (Lathrop et al. 1984), under the
assumption of linkage equilibrium with each marker un-
linked to a dummy locus (Terwilliger and Ott 1994).
Model-based linkage analysis was performed under both
recessive and dominant modes of inheritance (Hodge et
al. 1997; Morton 1998; Durner et al. 1999), and the
genotype relative risk of disease was varied from 10 to
100, for liability classes 1–3, and from 2 to 4, for liability
class 4. Since the diagnosis of tuberculosis was made in
some cases by clinical information rather than by pos-
itive cultures, the sensitivity of the results to each di-
agnosis was assessed. One by one, the phenotype of each
affected individual was altered to “unknown,” and the
analysis under a dominant model was repeated. Non-
parametric linkage analysis (Kruglyak 1997) based on
affected-member allele sharing (e.g., see Kruglyak et
al. 1996) was not attempted, because of both the size
of the pedigree and the presence of loops; however, a
model-free analysis was performed by a modified version
of the MFLINK program (Curtis and Sham 1995; C. M.
T. Greenwood and K. Morgan, unpublished data), a ver-
sion that allows more than one liability class.
Diallelic polymorphisms in NRAMP1 were tested for
association with disease, by examination of transmis-
sions from heterozygous parents. Since all transmis-
sions occur within the same family, under the assump-
tion of linkage without association the transmissions
are not independent. In fact, most of the counted trans-
missions are due to the segregation of one allele from
the oldest couple to their children and grandchildren.
Therefore, it was not possible to assess whether, in ad-
dition to linkage, there is significant association with
particular alleles.
Results
The epidemic in this rural community was carefully doc-
umented by Mah and Fanning (1991). One member re-
turned to live with the family and then developed symp-
tomatic tuberculosis that was undiagnosed for 4–5 mo.
Contact between all family members was thought to be
frequent; all nuclear families lived close to one another.
After diagnosis of the index case, a screening program
was implemented, and individuals were treated as nec-
essary. The extended family of 81 individuals (fig. 1)
includes 67 individuals who were clinically assessed, of
whom 61 were genotyped. An additional 14 ancestors
were included, to link members of the pedigree. Forty-
two individuals tested as being newly PPD positive dur-
ing the epidemic and, prior to the epidemic, had not
been either vaccinated or diagnosed as having tuber-
culosis. These individuals were assigned to liability class
1 (table 1). Liability class 2 included 11 individuals: 3
individuals who previously had been vaccinated with
BCG, 5 who were PPD positive prior to the epidemic,
and 3 who previously had been affected with tubercu-
losis and had been successfully treated. Seven individu-
als who never tested as PPD positive were assigned to
liability class 3, and seven very young or elderly indi-
viduals were assigned to the high-risk class 4. Of the 67
observed individuals, all 42 in liability class 1 were geno-
typed, 10 of 11 in class 2, 4 of 7 in class 3, and 5 of 7
in class 4.
Twenty-four members of the family became affected
with active tuberculosis during the 2 years following the
diagnosis of the index case (table 1). Seven individuals
were culture negative but were diagnosed by symptoms,
confirmatory X-ray, and response to treatment. All
seven were !10 years of age (5 of these 7 were !5 years
old); the sensitivity of culture diagnosis in young chil-
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Table 4
LOD Scores for Linkage under a Dominant Model, Genotype Relative Risk 10, and Disease-Allele
Frequency .05
MARKER
COMPOSITE
LOCATIONa
(Mb)
LOD SCORE AT RECOMBINATION FRACTION OF
.00 .01 .05 .10 .20 .40
Chromosome 2:
HOXD8 181.66 2.91 2.71 2.06 1.48 .76 .17
D2S152 194.26 1.65 1.58 1.29 .98 .50 .05
CRYG 221.82 1.22 1.21 1.13 1.00 .66 .07
D2S157 222.80 1.38 1.42 1.49 1.45 1.12 .08
D2S128b 226.87 1.23 1.28 1.37 1.37 1.12 .12
D2S137b 228.80 2.17 2.11 1.88 1.59 1.03 .10
TNP1 220.26 1.49 1.47 1.34 1.16 .78 .16
D2S301 230.49 2.08 2.06 1.95 1.75 1.26 .22
D2S164 230.60 .51 .51 .48 .43 .28 .01
D2S434 233.15 2.55 2.52 2.39 2.18 1.62 .19
D2S173c 232.32 2.71 2.72 2.65 2.45 1.86 .23
D2S104c 232.96 .90 .88 .80 .71 .47 .06
NRAMP1 (GT)n
d 227.21 3.55 3.49 3.26 2.92 2.16 .32
NRAMP1 D543Nd 227.21 3.21 3.18 2.99 2.71 2.02 .30
NRAMP1 haplotype 227.21 3.36 3.32 3.16 2.90 2.23 .38
D2S1471 … .79 .79 .78 .75 .61 .14
D2S433 232.84 .47 .49 .52 .51 .38 .07
D2S424 235.92 3.81 3.77 3.57 3.24 2.40 .35
D2S102 236.93 .51 .50 .45 .40 .32 .10
D2S126 236.26 3.11 3.09 2.96 2.71 2.04 .28
D2S172 246.68 1.20 1.25 1.37 1.39 1.16 .10
D2S125 253.37 2.93 2.82 2.41 1.90 1.04 .16
Chromosome 6:
TNFa … .07 .07 .05 .04 .02 .00
TNFb 37.81 1.48 1.39 1.07 .78 .42 .12
TNF haplotype 37.81 2.64 2.44 1.79 1.18 .48 .10
a From the Genetic Location Database, updated November 9, 1999. The order of the markers shown,
from TNP1 to D2S126, is based on physical mapping data, not on the Genetic Location Database estimated
order.
b The physical order of the markers within the pair D2S128 and D2S137 was not resolved.
c The physical order of the markers within the pair D2S173 and D2S104 was not resolved.
d The NRAMP1 orientation with respect to flanking markers has been derived from genomic sequence
information (S. Marquet and E. Schurr, unpublished data).
dren is known to be poor (Smith and Marquis 1987).
Four individuals had been diagnosed with tuberculosis
110 years prior to this epidemic. One of these old cases
(individual 1; see fig. 1) developed active disease during
the outbreak; this case may have been due to reacti-
vation of old disease, rather than to a new infection.
All cases were appropriately treated; in addition, control
measures led to izoniazid treatment for most PPD-pos-
itive individuals and other individuals identified as being
at high risk (Mah and Fanning 1991).
NRAMP1 Region
Table 4 shows the results of a LOD-score analysis
under a dominant model using the penetrances in table
1. For the purposes of this analysis, the individual who
experienced a second case of tuberculosis was considered
to be newly affected. The maximum LOD score of 3.81
was obtained for a recombination fraction of 0, with
D2S424, which is estimated to be 8.71 Mb away from
NRAMP1 (Genetic Location Database). Physical-map
data, however, estimate the distance to be bp.6! 2# 10
Under a recessive model, the maximum LOD score for
D2S424 was 2.8 and again occurred at 0 recombination.
Informativity of many markers in the region was incom-
plete. The NRAMP1 haplotype contributes 77 equiva-
lent (informative) meioses (Ott 1991), of a possible 97,
whereas the NRAMP1 missense variant (D543N; also
included in the NRAMP1 haplotype) contributed 40 in-
formative meioses.
Figure 3 illustrates the sensitivity of the results to the
disease status. One by one, the status of each affected
individual was altered to be unknown. The first point
on the left corresponds to the individual in the family
whose illness may have been due to a reactivation of
previous disease. The LOD score rose by ∼0.2 when the
affection status of this individual was considered to be
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Figure 3 Sensitivity of LOD-score results to the diagnosis of
an affected individual, for the NRAMP1 haplotype, two flanking mi-
crosatellite markers, and one intragenic polymorphism, D543N. LOD
scores in all cases were maximized over the recombination fraction.
Horizontal lines show the LOD scores for the original data. The order
along the horizontal axis corresponds to the identification numbers of
affected individuals in figure 1, with the exception of individuals 23
and 24, who were two culture-negative cases not shown in figure 1.
unknown instead of affected. Despite the variability,
none of the LOD scores for the NRAMP1 haplotype fell
to !3, and none of the LOD scores for D2S424 fell to
!3.5. When all high-risk individuals together in class 4
were assigned an unknown phenotype, the LOD scores
changed very little from their original values. Minimal
changes also were seen when the seven individuals in
liability class 3, who may have had false-negative PPD
tests, all were assigned an unknown affection status.
Results varied slightly when the disease-allele fre-
quency or the genotype relative risk were changed. The
frequency of allele Asn at codon 543 of NRAMP1 was
estimated to be 21% in the founders of the pedigree;
however, this allele is rare in Canadians of European
ancestry (Liu et al. 1995a). Reducing the allele frequency
to 1% in the linkage analysis resulted in a small increase
in the maximum LOD score for this marker, from 3.31
to 3.41. In order to evaluate the dependence of the results
on the assumed genetic model in a more robust manner,
the model-free approach of Curtis and Sham (1995) was
altered to allow multiple liability classes (C. M. T. Green-
wood and K. Morgan, unpublished data). Assuming that
the susceptibility locus could not confer a genotype risk
110, the algorithm searched over allele frequencies and
penetrances for dominant and recessive models that were
consistent with the prevalences in table 1. A model-free
LOD score of 2.68 was obtained for the NRAMP1
haplotype.
Because of the size and complexity of the pedigree,
multipoint analysis using all markers was impractical.
However, linkage analysis was undertaken with two
markers jointly (the NRAMP1 haplotype and D2S424),
and a maximum LOD score of 4.2 was obtained between
the two marker loci. Similarly, three-point linkage-anal-
ysis models that paired the NRAMP1 haplotype with
either D2S433, D2S1471, or D2S434 gave multilocus
LOD scores of 3.1, 3.8, and 3.8, respectively, and each
analysis estimated the location of the susceptibility locus
to be either at the NRAMP1 haplotype or between the
second marker and the NRAMP1 haplotype.
The alleles at all marker loci in the region were ex-
amined for association with disease status. Allele Asn of
the diallelic missense variant, D543N, appeared to be
associated with disease. In transmissions to affected chil-
dren from a heterozygous parent (when both parents
were typed), there were 11 transmissions of allele Asn,
versus only 2 transmissions of allele Asp; however, this
apparent association is mostly attributable to the link-
age of disease with the NRAMP1 haplotype 2. Similarly,
at 77385C/T, which is in the promoter region of
NRAMP1, allele T was transmitted 10 times (vs. 0 trans-
missions of allele C) from heterozygous parents. It can
be seen in figure 1 and table 2 that this pattern is entirely
due to the segregation of theNRAMP1 haplotype 2 from
individual 2. At the promoter-region polymorphism
(GT)n, we observed four transmissions of allele 288, ver-
sus 13 transmissions of allele 286, from heterozygous
parents.
HLA Region
Although the HLA region is thought to have a role
in tuberculosis progression (Meyer et al. 1998), it is still
unresolved whether genes in this region contribute to
tuberculosis susceptibility. In this pedigree, there was no
evidence for linkage between the susceptibility locus and
markers either in or near TNF (table 4) that are in the
HLA class III region; however, the six affected offspring
of the oldest couple all inherited identical TNF and
NRAMP1 haplotypes from one of their parents (table
5). This pattern of cosegregation of two unlinked loci
was unexpected, and potential reasons for the joint
transmissions were explored.
The possibility of gene-gene interaction between TNF
and NRAMP1 was evaluated in several ways. We did
not fit a two-gene model, because of the complexity of
the pedigree. However, we evaluated linkage to the TNF
haplotype while allowing the penetrances to vary with
the allele carried at D543N in NRAMP1. Similarly, we
evaluated linkage to the NRAMP1 haplotype and al-
lowed the penetrances to vary between carriers of the
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Table 5
Segregation of NRAMP1 and TNF Haplotypes from
the Spouse of Individual 1 to 17 Offspring
STATUS
HAPLOTYPEa
NO. OF SIBLINGS
(LIABILITY CLASS)NRAMP1 TNF
Affected b 2 3 6 (LC 1)
Unaffected 2 3 1 (LC 2)
1 3 1 (LC 3), 3 (LC 1)
2 4 1 (LC 2)
1 4 3 (LC 1), 2 (LC 2)
a Designations for NRAMP1 and TNF are as given
in tables 2 and 3, respectively.
b All affected offspring received the same haplotypes
at both genes. One BCG-vaccinated unaffected individ-
ual also received this haplotype combination, but all
other unaffected individuals received different haplo-
type combinations.
TNF haplotype transmitted to the six affected offspring
of the second generation (haplotype 3 in table 3) and
carriers of all other alleles. LOD scores for linkage to
the TNF haplotype were consistently !0, under several
interaction models. Because of insufficient data, we were
unable to estimate the penetrances in these models with
eight liability classes.
The pattern of joint transmission to the affected sib-
lings of the second generation might also be due to seg-
regation distortion that operates jointly on TNF and
NRAMP1. We examined the transmission of TNF and
NRAMP1 haplotypes for each typed parent-child pair
in the pedigree and found neither evidence for biased
segregation overall nor statistical evidence for a segre-
gation-pattern difference due to the gender of the parent
who transmitted the alleles ( ).P = .5
If it is assumed that near to NRAMP1 there is a sus-
ceptibility locus for tuberculosis but that the MHC locus
does not affect disease susceptibility, this pattern of joint
transmission could have occurred by chance. The prob-
ability that this would occur by chance can be calculated
as .037 (by examination of the probability of transmis-
sions of the TNF haplotype to a fixed set of 6 affected
individuals and to 5 of 11 unaffected individuals, given
that there were 11 transmissions to 17 children). If there
were no susceptibility locus near NRAMP1, then the
probability that the six affected siblings would receive
the alleles at two loci would be much smaller than 4%.
Discussion
An extended Aboriginal Canadian family that experi-
enced an epidemic of tuberculosis has shown evidence
for linkage between susceptibility for symptomatic dis-
ease and chromosome 2q35 loci near a strong candidate
gene, NRAMP1. The model-based analysis used four
liability classes in which the chosen high-risk penetrances
were based on the epidemiology of the disease. It has
been shown that, when the true mode of inheritance is
unknown, linkage can be robustly detected by estimation
of LOD scores for a small number of different sets of
penetrances (incomplete penetrance, dominant and re-
cessive models, and, perhaps, a range of genotype rel-
ative risks) and that this approach will lead to only a
small increase in the type I error rate (Hodge and Elston
1994; Hodge et al. 1997; Morton 1998; Durner et al.
1999).
The choice of penetrances (table 1), although, as far
as possible, based on knowledge of the disease epide-
miology, was somewhat arbitrary. Hence, we developed
and used a model-free approach, with multiple liability
classes, that maximized separately the numerator and
the denominator of the linkage likelihood ratio over the
disease-allele frequency, the mode of inheritance, and
penetrances that were compatible with fixed disease
prevalences. This robust analysis also found substantial
evidence in favor of linkage and lends support to the
traditional analysis.
In two-point linkage analysis, the estimated recom-
bination fractions between the susceptibility locus and
marker loci were all nearly 0 for markers close to or
withinNRAMP1. In analyses that included two markers
and the susceptibility locus, the location scores also es-
timated that the susceptibility locus was very near to
NRAMP1. However, it is known that multipoint anal-
ysis can result in more-biased estimates of the disease-
gene location if other parameters of the model are mis-
specified (Risch and Giuffra 1992; Terwilliger and Ott
1994; Halpern and Whittemore 1999). In all cases, a
1-LOD support interval for the location of the disease
gene spanned 10–15 cM on each side of NRAMP1. In
fact, for multilocus models, Terwilliger and Ott (1994)
recommended use of an interval wider than 1 LOD.
Therefore, we cannot rule out the possibility that tu-
berculosis susceptibility is affected by a gene closely
linked to but distinct from NRAMP1.
The construction of four liability classes defining dif-
ferent individual risks of overt disease was critical to
obtaining significant evidence for linkage. Although, for
complex diseases, it has been shown that simple LOD-
score models can outperform nonparametric methods
when the true model of inheritance is unknown (Hodge
et al. 1997; Greenberg et al. 1998; Abreu et al. 1999),
the availability of additional information about risk cat-
egories will improve the power to detect linkage (Hodge
et al. 1980). For an infectious disease such as tuber-
culosis, sufficient exposure to the causative agent is crit-
ical, and the incidence rate will increase with exposure
intensity (Ferguson 1955). Unfortunately, it is not pos-
sible to accurately measure exposure intensity. The four
liability classes represent our best assessments of both
the exposure and the susceptibility of each individual.
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An analysis that used these classes found strong evi-
dence for linkage for a variety of assumed penetrances
and disease-allele frequencies. However, an analysis that
did not make use of this epidemiological information
did not find significant evidence for linkage, no matter
what parameter values were assumed (data not shown).
Although allele 286 of the dinucleotide repeat in the
promoter region of NRAMP1 was reported to have
higher gene expression in vitro and was postulated to
be protective against infectious disease (Searle and
Blackwell 1999), we observed excess transmission of
this allele from heterozygous parents to affected chil-
dren. However, this finding does not provide any evi-
dence for or against a disease association with this allele,
since association and linkage are confounded in these
transmissions.
An attempt was made to study a second epidemic in
a similar setting, for the purposes of validating the ob-
served linkage to NRAMP1. During 1994–95, an epi-
demic of tuberculosis occurred in another community
of Aboriginal Canadians, who were from the same cul-
tural and linguistic heritage. A pedigree of 101 individ-
uals was analyzed for linkage; 18 individuals were di-
agnosed as having tuberculosis. There was no evidence
for or against linkage, since LOD scores were close to
0 (data not shown). There was a higher proportion of
individuals who were PPD negative, and the proportion
of individuals who contributed blood samples was
lower than that in the primary epidemic. Geographic
and social contact between family members was not as
close. Furthermore, because of both the number of in-
dividuals not genotyped and the pattern of affected in-
dividuals observed, the potential power to detect linkage
was low. No other epidemic of tuberculosis in Aborig-
inal Canadians from the same cultural and linguistic
heritage has become available for study.
In the mouse, Nramp1 does not appear to affect sus-
ceptibility to M. tuberculosis (Medina and North 1996;
North et al. 1999). The strongest evidence comes from
the North et al. (1999) study that used one strain of M.
tuberculosis (H37Rv) and 129sv mice homozygous for
functional deletion of Nramp1. Since M. tuberculosis is
not a natural pathogen of rodents, and since, in several
important aspects, M. tuberculosis–induced pathology
in mice differs from the human disease (e.g., in mice,
there is no latent phase, and the extent of granuloma
formation is different than that in humans), it is de-
batable whether infection of laboratory mice with M.
tuberculosis represents a good model for human tuber-
culosis. By contrast, M. microtis, a member of the M.
tuberculosis complex, is a natural pathogen of field and
forest mice and causes a tuberculosis-like disease (Lie´-
bana et al. 1996). Systematic investigations that address
the genetic control ofM.microtis infection in laboratory
mice are not available at present.
Because of the nature of the contacts between family
members in this kindred, most individuals probably
were exposed intensely to M. tuberculosis early during
the epidemic and became infected (table 1). Therefore,
the linkage of tuberculosis to NRAMP1 is consistent
with a phenotype of progression to overt disease rather
than susceptibility to infection, although, in the mouse,
Nramp1 controls early mycobacterial growth (Schurr
and Skamene 1995). Furthermore, mouse Nramp1 acts
dominantly to confer early-phase resistance to myco-
bacterial infection, whereas a dominant model for sus-
ceptibility appeared to be more likely in this family and
in the western Africans studied by Bellamy et al. (1998).
Allelic variants in mice differ in controlling the growth
rate of intracellular parasites (Vidal et al. 1995); both
intra- and interspecies differences in allelic variants and
in their function should be expected.
NRAMP1 appears to play a substantial role in af-
fecting disease susceptibility in this family. Under the
genetic model assumed here (table 1), carriers, in lia-
bility classes 1–3, of at least one copy of a high-risk
allele have a 10-fold-increased risk of disease, com-
pared with individuals with no copies of the high-risk
allele. However, in the study by Bellamy et al. (1998),
NRAMP1 variants were estimated as conferring small
relative risks for tuberculosis susceptibility (odds ratios
!2.0), and other studies have failed to find linkage of
tuberculosis to NRAMP1 (Shaw et al. 1997). In The
Gambia, almost all individuals had been infected (Bel-
lamy et al. 1998). In the Canadian community, BCG
vaccination lapsed in 1963 (Mah and Fanning 1991),
and only a few individuals had been exposed to tu-
berculosis prior to the epidemic. Hence, family mem-
bers likely had low levels of specific anti–M. tuber-
culosis immunity, and almost everyone might be
expected to have been susceptible to infection and dis-
ease. Furthermore, between the arrival of the index
case in the community and the initiation of a general
treatment and control program that would have low-
ered the exposure intensity, there was a period of in-
tense exposure lasting several months. Thus, in this
family, NRAMP1 appears to modulate the rate at
which individuals progress from being infected (i.e.,
PPD positive) to having symptomatic disease. Results
may have been very different if (a) the study had been
undertaken either in a context where exposure was less
intense, perhaps as in the attempted validation sample,
or under pandemic rather than epidemic conditions
where most individuals are continuously exposed to
M. tuberculosis or (b) if the timing of the treatment
and control program had been different. In conclusion,
in the epidemiological context of a tuberculosis out-
break in a community of Aboriginal Canadians, most
of whom had not been BCG vaccinated, there is sig-
nificant evidence to support a role for NRAMP1 or a
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gene (or genes) closely linked to NRAMP1 in suscep-
tibility to active tuberculosis disease.
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